Functional significance of adenosine in carotid body chemosensory activity in control and chronically hypoxic animals

ABSTRACT: Carotid bodies (CB) are peripheral chemoreceptor organs sensing changes in arterial blood O2, CO2 and pH levels. Hypoxia and acidosis or hypercapnia activates CB chemoreceptor cells, which respond by releasing neurotransmitters in order to increase the action potential frequency in their sensory nerve, the carotid sinus nerve (CSN). CSN activity is integrated in the brainstem to induce a fan of cardiorespiratory reflex responses, aimed at normalising the altered blood gases. Exogenously applied adenosine (Ado) increases CSN chemosensory activity inducing hyperventilation through activation of A2 receptors. The importance of the effects of adenosine in chemoreception was reinforced by data obtained in humans, in which the intravenous infusion of Ado causes hyperventilation and dyspnoea, an effect that has been attributed to the activation of CB because Ado does not cross blood-brain barrier and because the ventilatory effects are higher the closer to the CB it is injected. The present work was performed in order to establish the functional significance of adenosine in chemoreception at the carotid body in control and chronically hypoxic rats. To achieve this objective we investigated: 1) The release of adenosine from a rat carotid body in vitro preparation in response to moderate hypoxia and the specificity of this release. We also investigated the metabolic pathways of adenosine production and release in the organ in normoxia and hypoxia; 2) The modulation of adenosine/ATP release from rat carotid body chemoreceptor cells by nicotinic ACh receptors; 3) The effects of caffeine on peripheral control of breathing and the identity of the adenosine receptors involved in adenosine and caffeine effects on carotid body chemoreceptors; 4) The interactions between dopamine D2 receptors and adenosine A2B receptors that modulate the release of catecholamines (CA) from the rat carotid body; 5) The effect of chronic caffeine intake i.e. the continuous blockage of adenosine receptors thereby simulating a caffeine dependence, on the carotid body function in control and chronically hypoxic rats. The methodologies used in this work included: molecular biology techniques (e.g. immunocytochemistry and western-blot), biochemical techniques (e.g. neurotransmitter quantification by HPLC, bioluminescence and radioisotopic methods), electrophysiological techniques (e.g. action potential recordings) and ventilatory recordings using whole-body plethysmography. It was observed that: 1) CB chemoreceptor sensitivity to hypoxia could be related to its low threshold for the release of adenosine because moderate acute hypoxia (10% O2) increased adenosine concentrations released from the CB by 44% but was not a strong enough stimulus to evoke adenosine release from superior cervical ganglia and arterial tissue; 2) Acetylcholine (ACh) modulates the release of adenosine/5’-adenosine triphosphate (ATP) from CB in moderate hypoxia through the activation of nicotinic receptors with α4 and ß2 receptor subunits, suggesting that the excitatory role of ACh in chemosensory activity includes indirect activation of purinergic receptors by adenosine and ATP, which strongly supports the hypothesis that ATP/adenosine are important mediators in chemotransduction; 3) adenosine increases the release of CA from rat CB chemoreceptor cells via A2B receptors; 4) the inhibitory effects of caffeine on CB chemoreceptors are mediated by antagonism of postsynaptic A2A and presynaptic A2B adenosine receptors indicating that chemosensory activity elicited by hypoxia is controlled by adenosine; 5) The release of CA from rat CB chemoreceptor cells is modulated by adenosine through an antagonistic interaction between A2B and D2 receptors, for the first time herein described; 6) chronic caffeine treatment did not significantly alter the basal function of CB in normoxic rats assessed as the dynamics of their neurotransmitters, dopamine, ATP and adenosine, and the CSN chemosensory activity. In contrast, the responses to hypoxia in these animals were facilitated by chronic caffeine intake because it increased the ventilatory response, slightly increased CSN chemosensory activity and increased dopamine (DA) and ATP release; 7) In comparison with normoxic rats, chronically hypoxic rats exhibited an increase in several parameters: ventilatory hypoxic response; basal and hypoxic CSN activity; tyrosine hydroxylase expression, CA content, synthesis and release; basal and hypoxic adenosine release; and in contrast a normal basal release and diminished hypoxia-induced ATP release; 8) Finally, in contrast to chronically hypoxic rats, chronic caffeine treatment did not alter the basal CSN chemosensory activity. Nevertheless, the responses to mild and intense hypoxia, and hypercapnia, were diminished. This inhibitory effect of chronic caffeine in CB output is compensated by central mechanisms, as the minute ventilation parameter in basal conditions and in response to acute hypoxic challenges remained unaltered in rats exposed to chronic hypoxia. We can conclude that adenosine both in acute and chronically hypoxic conditions have an excitatory role in the CB chemosensory activity, acting directly on adenosine A2A receptors present postsynaptically in CSN, and acting presynaptically via A2B receptors controlling the release of dopamine in chemoreceptor cells. We suggest that A2B -D2 adenosine / dopamine interactions at the CB could explain the increase in CA metabolism caused by chronic ingestion of caffeine during chronic hypoxia. It was also concluded that adenosine facilitates CB sensitisation to chronic hypoxia although this effect is further compensated at the central nervous system.-------- RESUMO: Os corpos carotídeos (CB) são pequenos orgãos emparelhados localizados na bifurcação da artéria carótida comum. Estes órgãos são sensíveis a variações na PaO2, PaCO2, pH e temperatura sendo responsáveis pela hiperventilação que ocorre em resposta à hipóxia, contribuindo também para a hiperventilação que acompanha a acidose metabólica e respiratória. As células quimiorreceptoras (tipo I ou glómicas) do corpo carotídeo respondem às variações de gases arteriais libertando neurotransmissores que activam as terminações sensitivas do nervo do seio carotídeo (CSN) conduzindo a informação ao centro respiratório central. Está ainda por esclarecer qual o neurotransmissor (ou os neurotransmissores) responsável pela sinalização hipóxica no corpo carotídeo. A adenosina é um neurotransmissor excitatório no CB que aumenta a actividade eléctrica do CSN induzindo a hiperventilação através da activação de receptores A2. A importância destes efeitos da adenosina na quimiorrecepção, descritos em ratos e gatos, foi reforçada por resultados obtidos em voluntários saudáveis onde a infusão intravenosa de adenosina em induz hiperventilação e dispneia, efeito atribuído a uma activação do CB uma vez que a adenosina não atravessa a barreira hemato-encefálica e o efeito é quanto maior quanto mais perto do CB for a administração de adenosina. O presente trabalho foi realizado com o objectivo de esclarecer qual o significado funcional da adenosina na quimiorrecepção no CB em animais controlo e em animais submetidos a hipoxia crónica mantida. Para alcançar este objectivo investigou-se: 1) o efeito da hipóxia moderada sobre a libertação de adenosina numa preparação in vitro de CB e a especificidade desta mesma libertação comparativamente com outros tecidos não quimiossensitivos, assim como as vias metabólicas de produção e libertação de adenosina no CB em normoxia e hipóxia; 2) a modulação da libertação de adenosina/ATP das células quimiorreceptoras do CB por receptores nicotínicos de ACh; 3) os efeitos da cafeína no controlo periférico da ventilação e a identidade dos receptores de adenosina envolvidos nos efeitos da adenosina e da cafeína nos quimiorreceptores do CB; 4) as interacções entre os receptores D2 de dopamina e os receptores A2B de adenosina que modulam a libertação de catecolaminas (CA) no CB de rato e; 5) o efeito da ingestão crónica de cafeína, isto é, o contínuo bloqueio e dos receptores de adenosina, simulando assim o consumo crónico da cafeína, tal como ocorre na população humana mundial e principalmente no ocidente, na função do corpo carotídeo em ratos controlo e em ratos submetidos a hipoxia crónica. Os métodos utilizados neste trabalho incluíram: técnicas de biologia molecular como imunocitoquímica e western-blot; técnicas bioquímicas, tais como a quantificação de neurotransmissores por HPLC, bioluminescência e métodos radioisotópicos; técnicas electrofisiológicas como o registro de potenciais eléctricos do nervo do seio carotídeo in vitro; e registros ventilatórios in vivo em animais não anestesiados e em livre movimento (pletismografia). Observou-se que: 1) a especificidade dos quimiorreceptores do CB como sensores de O2 está correlacionada com o baixo limiar de libertação de adenosina em resposta à hipóxia dado que a libertação de adenosina do CB aumenta 44% em resposta a uma hipóxia moderada (10% O2), que no entanto não é um estímulo suficientemente intenso para evocar a libertação de adenosina do gânglio cervical superior ou do tecido arterial. Observou-se também que aproximadamente 40% da adenosina libertada pelo CB provém do catabolismo extracelular do ATP quer em normóxia quer em hipóxia moderada, sendo que PO2 reduzidas induzem a libertação de adenosina via activação do sistema de transporte equilibrativo ENT1. 2) a ACh modula a libertação de adenosina /ATP do CB em resposta à hipoxia moderada sugerindo que o papel excitatório da ACh na actividade quimiossensora inclui a activação indirecta de receptores purinérgicos pela adenosina e ATP, indicando que a adenosina e o ATP poderiam actuar como mediadores importantes no processo de quimiotransducção uma vez que: a) a activação dos receptores nicotínicos de ACh no CB em normóxia estimula a libertação de adenosina (max 36%) provindo aparentemente da degradação extracelular do ATP. b) a caracterização farmacológica dos receptores nicotínicos de ACh envolvidos na estimulação da libertação de adenosina do CB revelou que os receptores nicotínicos de ACh envolvidos são constituídos por subunidades α4ß2. 3) a adenosina modula a libertação de catecolaminas das células quimiorreceptoras do CB através de receptores de adenosina A2B dado que: a)a cafeína, um antagonista não selectivo dos receptores de adenosina, inibiu a libertação de CA quer em normóxia quer em resposta a estímulos de baixa intensidade sendo ineficaz na libertação induzida por estímulos de intensidade superior; b) o DPCPX e do MRS1754 mimetizaram os efeitos da cafeína no CB sendo o SCH58621 incapaz de induzir a libertação de CA indicando que os efeitos da cafeína seriam mediados por receptores A2B de adenosina cuja presença nas células quimiorreceptoras do CB demonstramos por imunocitoquímica. 4) a aplicação aguda de cafeína inibiu em 52% a actividade quimiossensora do CSN induzida pela hipóxia sendo este efeito mediado respectivamente por receptores de adenosina A2A pós-sinápticos e A2B pré-sinápticos indicando que a actividade quimiossensora induzida pela hipóxia é controlada pela adenosina. 5) existe uma interacção entre os receptores A2B e D2 que controla a libertação de CA do corpo carotídeo de rato uma vez que: a) os antagonistas dos receptores D2, domperidona e haloperidol, aumentaram a libertação basal e evocada de CA das células quimiorreceptoras confirmando a presença de autorreceptores D2 no CB de rato que controlam a libertação de CA através de um mecanismo de feed-back negativo. b) o sulpiride, um antagonista dos receptores D2, aumentou a libertação de CA das células quimiorreceptoras revertendo o efeito inibitório da cafeína sobre esta mesma libertação; c) a propilnorapomorfina, um agonista D2 inibiu a libertação basal e evocada de CA sendo este efeito revertido pela NECA, um agonista dos receptores A2B. O facto de a NECA potenciar o efeito do haloperidol na libertação de CA sugere que a interacção entre os receptores D2 e A2B poderia também ocorrer ao nível de segundos mensageiros, como o cAMP. 6) a ingestão crónica de cafeína em ratos controlo (normóxicos) não alterou significativamente a função basal do CB medida como a dinâmica dos seus neurotransmissores, dopamina, ATP e adenosina e como actividade quimiossensora do CSN. Contrariamente aos efeitos basais, a ingestão crónica de cafeína facilitou a resposta à hipóxia, dado que aumentou o efeito no volume minuto respiratórioapresentando-se também uma clara tendência para aumentar a actividade quimiossensora do CSN e aumentar a libertação de ATP e dopamina.7) após um período de 15 dias de hipóxia crónica era evidente o fenómeno de aclimatização dado que as respostas ventilatórias à hipóxia se encontram aumentadas, assim como a actividade quimiossensora do CSN basal e induzida pela hipóxia. As alterações observadas no metabolismo da dopamina, assim como na libertação basal de dopamina e de adenosina poderiam contribuir para a aclimatização durante a hipoxia crónica. A libertação aumentada de adenosina em resposta à hipóxia aguda em ratos hipóxicos crónicos sugere um papel da adenosina na manutenção/aumento das respostas ventilatórias à hipóxia aguda durante a hipóxia crónica. Observou-se também que a libertação de ATP induzida pela hipóxia aguda se encontra diminuída em hipóxia crónica, contudo a ingestão crónica de cafeína reverteu este efeito para valores similares aos valores controlo, sugerindo que a adenosina possa modular a libertação de ATP em hipóxia crónica. 8) a ingestão crónica de cafeína em ratos hipóxicos crónicos induziu o aumento do metabolismo de CA no CB, medido como expressão de tirosina hidroxilase, conteúdo, síntese e libertação de CA. 9) a ingestão crónica de cafeína não provocou quaisquer alterações na actividade quimiossensora do CSN em ratos hipóxicos crónicos no entanto, as respostas do CSN à hipóxia aguda intensa e moderada e à hipercapnia encontram-se diminuídas. Este efeito inibitório que provém da ingestão crónica de cafeína parece ser compensado ao nível dos quimiorreceptores centrais dado que os parâmetros ventilatórios em condições basais e em resposta à hipoxia aguda não se encontram modificados em ratos expostos durante 15 dias a uma atmosfera hipóxica. Resumindo podemos assim concluir que a adenosina quer em situações de hipoxia aguda quer em condições de hipoxia crónica tem um papel excitatório na actividade quimiossensora do CB actuando directamente nos receptores A2A presentes pós-sinapticamente no CSN, assim como facilitando a libertação de dopamina pré-sinapticamente via receptores A2B presentes nas células quimiorreceptoras. A interacção negativa entre os receptores A2B e D2 observadas nas células quimiorreceptoras do CB poderia explicar o aumento do metabolismo de CA observado após a ingestão crónica de cafeína em animais hipóxicos. Conclui-se ainda que durante a aclimatização à hipóxia a acção inibitória da cafeína, em termos de resposta ventilatória, mediada pelos quimiorreceptores periféricos é compensada pelos efeitos excitatórios desta xantina ao nível do quimiorreceptores centrais.------- RESUMEN Los cuerpos carotídeos (CB) son órganos emparejados que están localizados en la bifurcación de la arteria carótida común. Estos órganos son sensibles a variaciones en la PaO2, en la PaCO2, pH y temperatura siendo responsables de la hiperventilación que ocurre en respuesta a la hipoxia, contribuyendo también a la hiperventilación que acompaña a la acidosis metabólica y respiratoria. Las células quimiorreceptoras (tipo I o glómicas) del cuerpo carotídeo responden a las variaciones de gases arteriales liberando neurotransmissores que activan las terminaciones sensitivas del nervio del seno carotídeo (CSN) llevando la información al centro respiratorio central. Todavía esta por clarificar cual el neurotransmisor (o neurotransmisores) responsable por la señalización hipóxica en el CB. La adenosina es un neurotransmisor excitatório en el CB ya que aumenta la actividad del CSN e induce la hiperventilación a través de la activación de receptores de adenosina del subtipo A2. La importancia de estos efectos de la adenosina en la quimiorrecepción, descritos en ratas y gatos, ha sido fuertemente reforzada por resultados obtenidos en voluntarios sanos en los que la infusión intravenosa de adenosina induce hiperventilación y dispnea, efectos estés que han sido atribuidos a una activación del CB ya que la adenosina no cruza la barrera hemato-encefalica y el efecto es tanto más grande cuanto más cercana del CB es la administración. Este trabajo ha sido realizado con el objetivo de investigar cual el significado funcional de la adenosina en la quimiorrecepción en el CB en animales controlo y en animales sometidos a hipoxia crónica sostenida. Para alcanzar este objetivo se ha estudiado: 1) el efecto de la hipoxia moderada en la liberación de adenosina en una preparación in vitro de CB y la especificidad de esta liberación en comparación con otros tejidos no-quimiosensitivos, así como las vías metabólicas de producción y liberación de adenosina del órgano en normoxia y hipoxia; 2) la modulación de la liberación de adenosina/ATP de las células quimiorreceptoras del CB por receptores nicotínicos de ACh; 3) los efectos de la cafeína en el controlo periférico de la ventilación y la identidad de los receptores de adenosina involucrados en los efectos de la adenosina y cafeína en los quimiorreceptores del CB; 4) las interacciones entre los receptores D2 de dopamina y los receptores A2B de adenosina que modulan la liberación de catecolaminas (CA) en el CB de rata y; 5) el efecto de la ingestión crónica de cafeína, es decir, el bloqueo sostenido de los receptores de adenosina, simulando la dependencia de cafeína observada en la populación mundial del occidente, en la función del CB en ratas controlo y sometidas a hipoxia crónica sostenida. Los métodos utilizados en este trabajo incluirán: técnicas de biología molecular como imunocitoquímica y western-blot; técnicas bioquímicas, tales como la cuantificación de neurotransmissores por HPLC, bioluminescencia y métodos radioisotópicos; técnicas electrofisiológicas como el registro de potenciales eléctricos del nervio do seno carotídeo in vitro; y registros ventilatórios in vivo en animales no anestesiados y en libre movimiento (pletismografia). Se observó que: 1) la sensibilidad de los quimiorreceptores de CB esta correlacionada con un bajo umbral de liberación de adenosina en respuesta a la hipoxia ya que en respuesta a una hipoxia moderada (10% O2) la liberación de adenosina en el CB aumenta un 44%, sin embargo esta PaO2 no es un estimulo suficientemente fuerte para inducir la liberación de adenosina del ganglio cervical superior o del tejido arterial; se observó también que aproximadamente 40% de la adenosina liberada del CB proviene del catabolismo extracelular del ATP en normoxia y en hipoxia moderada, y que bajas PO2 inducen la liberación de adenosina vía activación del sistema de transporte equilibrativo ENT1. 2) la ACh modula la liberación de adenosina /ATP del CB en respuesta a la hipóxia moderada lo que sugiere que el papel excitatório de la ACh en la actividad quimiosensora incluye la activación indirecta de receptores purinérgicos por la adenosina y el ATP, indicando que la adenosina y el ATP pueden actuar como mediadores importantes en el proceso de quimiotransducción ya que: a) la activación de los receptores nicotínicos de ACh en el CB en normoxia estimula la liberación de adenosina (max 36%) que aparentemente proviene de la degradación extracelular del ATP. Se observó también que este aumento de adenosina en el CB en hipoxia ha sido antagonizado parcialmente por antagonistas de estos mismos receptores; b) la caracterización farmacológica de los receptores nicotínicos de ACh involucrados en la estimulación de la liberación de adenosina del CB ha revelado que los receptores nicotínicos de ACh involucrados son constituidos por sub-unidades α4ß2. 3) la adenosina modula la liberación de CA de las células quimiorreceptoras del CB a través de receptores de adenosina A2B ya que: a) la cafeína, un antagonista no selectivo de los receptores de adenosina, ha inhibido la liberación de CA en normoxia y en respuesta a estímulos de baja intensidad siendo ineficaz en la liberación inducida por estímulos de intensidad superior; b) el DPCPX y el MRS1754 ha mimetizado los efectos de la cafeína en el CB y el SCH58621 ha sido incapaz de inducir la liberación de CA lo que sugiere que los efectos de la cafeína son mediados por receptores A2B de adenosina que están localizados pré-sinapticamente en las células quimiorreceptoras del CB. 4) la aplicación aguda de cafeína ha inhibido en 52% la actividad quimiosensora del CSN inducida por la hipoxia siendo este efecto mediado respectivamente por receptores de adenosina A2A pós-sinápticos y A2B pré-sinápticos lo que indica que la actividad quimiosensora inducida por la hipoxia es controlada por la adenosina. 5) existe una interacción entre los receptores A2B y D2 que controla la liberación de CA del CB de rata ya que: a) el sulpiride, un antagonista de los receptores D2, ha aumentado la liberación de CA de las células quimiorreceptoras revertiendo el efecto inhibitorio de la cafeína sobre esta misma liberación; b) los antagonistas de los receptores D2, domperidona y haloperidol, han aumentado la liberación basal e evocada de CA de las células quimiorreceptoras confirmando la presencia de autorreceptores D2 en el CB de rata que controlan la liberación de CA a través de un mecanismo de feed-back negativo; c) la propilnorapomorfina, un agonista D2, ha inhibido la liberación basal e evocada de CA sendo este efecto revertido por la NECA, un agonista de los receptores A2B. Ya que la NECA potencia el efecto del haloperidol en la liberación de CA la interacción entre los D2 y A2B puede también ocurrir al nivel de segundos mensajeros, como el cAMP. 6) la ingestión crónica de cafeína en ratas controlo (normóxicas) no ha cambiado significativamente la función basal del CB medida como la dinámica de sus neurotransmisores, dopamina, ATP y adenosina y como actividad quimiosensora del CSN. Al revés de lo que pasa con los efectos básales, la ingestión crónica de cafeína facilitó la respuesta a la hipóxia, ya que ha aumentado la respuesta ventilatória medida como volumen minuto presentando también una clara tendencia para aumentar la actividad quimiosensora del CSN y aumentar la liberación de ATP y dopamina. 7. Después de un período de 15 días de hipoxia crónica se puede observar el fenómeno de climatización ya que las respuestas ventilatórias a la hipoxia están aumentadas, así como la actividad quimiosensora del CSN basal e inducida por la hipoxia. Los cambios observados en el metabolismo de la dopamina, así como en la liberación basal de dopamina y de adenosina podrían contribuir para la climatización en hipoxia crónica. El aumento en la liberación de adenosina en respuesta a la hipoxia aguda en ratas sometidas a hipoxia crónica sugiere un papel para la adenosina en el mantenimiento/aumento de las respuestas ventilatórias a la hipoxia aguda en hipoxia crónica sostenida. Se ha observado también que la liberación de ATP inducida por la hipoxia aguda está disminuida en hipoxia crónica y que la ingestión crónica de cafeína reverte este efecto para valores similares a los valores controlo, sugiriendo que la adenosina podría modular la liberación de ATP en hipoxia crónica. 8. la ingestión crónica de cafeína ha inducido el aumento del metabolismo de CA en el CB en ratas hipóxicas crónicas, medido como expresión de la tirosina hidroxilase, contenido, síntesis y liberación de CA. 9. la ingestión crónica de cafeína no ha inducido cambios en la actividad quimiosensora del CSN en ratas hipóxicas crónicas sin embargo las respuestas do CSN a una hipoxia intensa y moderada y a la hipercapnia están disminuidas. Este efecto inhibitorio que es debido a la ingestión crónica de cafeína es compensado al nivel de los quimiorreceptores centrales ya que los parámetros ventilatórios en condiciones básales y en respuesta a la hipoxia aguda no están modificados en ratas expuestas durante 15 días a una atmósfera hipóxica. Resumiendo se puede concluir que la adenosina en situaciones de hipoxia aguda así como en hipoxia crónica tiene un papel excitatório en la actividad quimiosensora del CB actuando directamente en los receptores A2A localizados pós-sinapticamente en el CSN, así como controlando la liberación de dopamina pré-sinaptica vía receptores A2B localizados en las células quimiorreceptoras. Las interacciones entre los receptores A2B y D2 observadas en las células quimiorreceptoras del CB podrían explicar el aumento del metabolismo de CA observado después de la ingestión crónica de cafeína en animales hipóxicos. Por fin, pero no menos importante se puede concluir que durante la climatización a la hipoxia la acción inhibitoria de la cafeína, medida como respuesta ventilatória, mediada por los quimiorreceptores periféricos es compensada por los efectos excitatórios de esta xantina al nivel de los quimiorreceptores centrales.

Valor Prognóstico da Normalização da Resposta Ventilatória ao Exercício para o Consumo Máximo de Oxigénio na Insuficiência Cardíaca

Cardiopulmonary exercise testing (CPET) is an objective method for assessment of functional capacity and for prognostic stratification of patients with chronic heart failure (CHF). In this study, we analyzed the prognostic value of a recently described CPET-derived parameter, the minute ventilation to carbon dioxide production slope normalized for peak oxygen consumption (VE/VCO2 slope/pVO2). METHODS: We prospectively studied 157 patients with stable CHF and dilated cardiomyopathy who performed maximal CPET using the modified Bruce protocol. The prognostic value of VE/VCO2 slope/pVO2 was determined and compared with traditional CPET parameters. RESULTS: During follow-up 37 patients died and 12 were transplanted. Mean follow-up in surviving patients was 29.7 months (12-36). Cox multivariate analysis revealed that VE/VCO2 slope/pVO2 had the greatest prognostic power of all the parameters studied. A VE/VCO2 slope/pVO2 of > or = 2.2 signaled cases at higher risk. CONCLUSION: Normalization of the ventilatory response to exercise for peak oxygen consumption appears to increase the prognostic value of CPET in patients with CHF.

Responses to exercise in normobaric hypoxia: comparison of elite and recreational ski mountaineers.

PURPOSE: Hypoxia is known to reduce maximal oxygen uptake (VO(2max)) more in trained than in untrained subjects in several lowland sports. Ski mountaineering is practiced mainly at altitude, so elite ski mountaineers spend significantly longer training duration at altitude than their lower-level counterparts. Since acclimatization in hypobaric hypoxia is effective, the authors hypothesized that elite ski mountaineers would exhibit a VO2max decrement in hypoxia similar to that of recreational ski mountaineers. METHODS: Eleven elite (E, Swiss national team) and 12 recreational (R) ski mountaineers completed an incremental treadmill test to exhaustion in normobaric hypoxia (H, 3000 m, F(1)O(2) 14.6% ± 0.1%) and in normoxia (N, 485 m, F(1)O(2) 20.9% ± 0.0%). Pulse oxygen saturation in blood (SpO(2)), VO(2max), minute ventilation, and heart rate were recorded. RESULTS: At rest, hypoxic ventilatory response was higher (P < .05) in E than in R (1.4 ± 1.9 vs 0.3 ± 0.6 L · min⁻¹ · kg⁻¹). At maximal intensity, SpO(2) was significantly lower (P < .01) in E than in R, both in N (91.1% ± 3.3% vs 94.3% ± 2.3%) and in H (76.4% ± 5.4% vs 82.3% ± 3.5%). In both groups, SpO(2) was lower (P < .01) in H. Between N and H, VO(2max) decreased to a greater extent (P < .05) in E than in R (-18% and -12%, P < .01). In E only, the VO(2max) decrement was significantly correlated with the SpO(2) decrement (r = .74, P < .01) but also with VO(2max) measured in N (r = .64, P < .05). CONCLUSION: Despite a probable better acclimatization to altitude, VO(2max) was more reduced in E than in R ski mountaineers, confirming previous results observed in lowlander E athletes.

Energy expenditure during walking and running in obese and nonobese prepubertal children.

We measured body composition and energy expenditure during walking and running on a treadmill in 40 prepubertal children: 23 obese children (9.3 +/- 1.1 years of age; 46 +/- 10 kg (mean +/- SD)) and 17 nonobese matched control children (9.2 +/- 0.6 years of age; 30 +/- 5 kg). Energy expenditure was assessed by indirect calorimetry with a standard open-circuit method. At the same speed of exercise, the energy expenditure was significantly (p < 0.01) greater in obese than in control children, in both boys and girls. Expressed per kilogram of body weight or per kilogram of fat-free mass, the energy expenditure was comparable in the two groups. Obese children had a significantly (p < 0.01) larger pulmonary ventilatory response to exercise than did control children. Heart rate was comparable in boys and girls combined but significantly higher (p < 0.05) in obese subjects, if boys and girls were analyzed separately. These data indicate that walking and running are energetically more expensive for obese children than for children of normal body weight. The knowledge of these energy costs could be useful in devising a physical activity program to be used in the treatment of obese children.

Effect of hypoxia on cerebral blood flow regulation during rest and exercise : role of cerebral oxygen delivery on performance

Adequate supply of oxygen to the brain is critical for maintaining normal brain function. Severe hypoxia, such as that experienced during high altitude ascent, presents a unique challenge to brain oxygen (O2) supply. During high-intensity exercise, hyperventilation-induced hypocapnia leads to cerebral vasoconstriction, followed by reductions in cerebral blood flow (CBF), oxygen delivery (DO2), and tissue oxygenation. This reduced O2 supply to the brain could potentially account for the reduced performance typically observed during exercise in severe hypoxic conditions. The aims of this thesis were to document the effect of acute and chronic exposure to hypoxia on CBF control, and to determine the role of cerebral DO2 and tissue oxygenation in limiting performance during exercise in severe hypoxia. We assessed CBF, arterial O2 content (CaO2), haemoglobin concentration ([Hb]), partial pressure of arterial O2 (PaO2), cerebrovascular CO2 reactivity, ventilatory response to CO2, cerebral autoregulation (CA), and estimated cerebral DO2 (CBF ⨉ CaO2) at sea level (SL), upon ascent to 5,260 m (ALT1), and following 16 days of acclimatisation to 5,260 m (ALT16). We found an increase in CBF despite an elevated cerebrovascular CO2 reactivity at ALT1, which coincided with a reduced CA. Meanwhile, PaO2 was greatly decreased despite increased ventilatory drive at ALT1, resulting in a concomitant decrease in CaO2. At ALT16, CBF decreased towards SL values, while cerebrovascular CO2 reactivity and ventilatory drive were further elevated. Acclimatisation increased PaO2, [Hb], and therefore CaO2 at ALT16, but these changes did not improve CA compared to ALT1. No differences were observed in cerebral DO2 across SL, ALT1, and ALT16. Our findings demonstrate that cerebral DO2 is maintained during both acute and chronic exposure to 5,260 m, due to the reciprocal changes in CBF and CaO2. We measured middle cerebral artery velocity (MCAv: index of CBF), cerebral DO2, ventilation (VE), and performance during incremental cycling to exhaustion and 15km time trial cycling in both normoxia and severe hypoxia (11% O2, normobaric), with and without added CO2 to the inspirate (CO2 breathing). We found MCAv was higher during exercise in severe hypoxia compared in normoxia, while cerebral tissue oxygenation and DO2 were reduced. CO2 breathing was effective in preventing the development of hyperventilation-induced hypocapnia during intense exercise in both normoxia and hypoxia. As a result, we were able to increase both MCAv and cerebral DO2 during exercise in hypoxia with our CO2 breathing setup. However, we concomitantly increased VE and PaO2 (and presumably respiratory work) due to the increased hypercapnic stimuli with CO2 breathing, which subsequently contributed to the cerebral DO2 increase during hypoxic exercise. While we effectively restored cerebral DO2 during exercise in hypoxia to normoxic values with CO2 breathing, we did not observe any improvement in cerebral tissue oxygenation or exercise performance. Accordingly, our findings do not support the role of reduced cerebral DO2 in limiting exercise performance in severe hypoxia. -- Un apport adéquat en oxygène au niveau du cerveau est primordial pour le maintien des fonctions cérébrales normales. L'hypoxie sévère, telle qu'expérimentée au cours d'ascensions en haute altitude, présente un défi unique pour l'apport cérébral en oxygène (O2). Lors d'exercices à haute intensité, l'hypocapnie induite par l'hyperventilation entraîne une vasoconstriction cérébrale suivie par une réduction du flux sanguin cérébral (CBF), de l'apport en oxygène (DO2), ainsi que de l'oxygénation tissulaire. Cette réduction de l'apport en O2 au cerveau pourrait potentiellement être responsable de la diminution de performance observée au cours d'exercices en condition d'hypoxie sévère. Les buts de cette thèse étaient de documenter l'effet de l'exposition aiguë et chronique à l'hypoxie sur le contrôle du CBF, ainsi que de déterminer le rôle du DO2 cérébral et de l'oxygénation tissulaire comme facteurs limitant la performance lors d'exercices en hypoxie sévère. Nous avons mesuré CBF, le contenu artériel en oxygène (CaO2), la concentration en hémoglobine ([Hb]), la pression partielle artérielle en O2 (PaO2), la réactivité cérébrovasculaire au CO2, la réponse ventilatoire au CO2, et l'autorégulation cérébrale sanguine (CA), et estimé DO2 cérébral (CBF x CaO2), au niveau de la mer (SL), au premier jour à 5.260 m (ALT1) et après seize jours d'acclimatation à 5.260 m (ALT16). Nous avons trouvé des augmentations du CBF et de la réactivité cérébrovasculaire au CO2 après une ascension à 5.260 m. Ces augmentations coïncidaient avec une réduction de l'autorégulation cérébrale. Simultanément, la PaO2 était grandement réduite, malgré l'augmentation de la ventilation (VE), résultant en une diminution de la CaO2. Après seize jours d'acclimatation à 5.260 m, le CBF revenait autour des valeurs observées au niveau de la mer, alors que la réactivité cérébrovasculaire au CO2 et la VE augmentaient par rapport à ALT1. L'acclimatation augmentait la PaO2, la concentration en hémoglobine, et donc la CaO2, mais n'améliorait pas l'autorégulation cérébrale, comparé à ALT1. Aucune différence n'était observée au niveau du DO2 cérébral entre SL, ALT1 et ALT16. Nos résultats montrent que le DO2 cérébral est maintenu constant lors d'expositions aiguë et chronique à 5.260m, ce qui s'explique par la réciprocité des variations du CBF et de la CaO2. Nous avons mesuré la vitesse d'écoulement du sang dans l'artère cérébrale moyenne (MCAv : un indice du CBF), le DO2 cérébral, la VE et la performance lors d'exercice incrémentaux jusqu'à épuisement sur cycloergomètre, ainsi que des contre-la-montres de 15 km en normoxie et en hypoxie sévère (11% O2, normobarique) ; avec ajout ou non de CO2 dans le mélange gazeux inspiré. Nous avons trouvé que MCAv était plus haute pendant l'exercice hypoxique, comparé à la normoxie alors que le DO2 cérébral était réduit. L'ajout de CO2 dans le gaz inspiré était efficace pour prévenir l'hypocapnie induite par l'hyperventilation, qui se développe à l'exercice intense, à la fois en normoxie et en hypoxie. Nous avons pu augmenter MCAv et le DO2 cérébral pendant l'exercice hypoxique, grâce à l'ajout de CO2. Cependant, nous avons augmenté la VE et la PaO2 (et probablement le travail respiratoire) à cause de l'augmentation du stimulus hypercapnique. Alors que nous avons, grâce à l'ajout de CO2, efficacement restauré le DO2 cérébral au cours de l'exercice en hypoxie à des valeurs obtenues en normoxie, nous n'avons observé aucune amélioration dans l'oxygénation du tissu cérébral ou de la performance. En conséquence, nos résultats ne soutiennent pas le rôle d'un DO2 cérébral réduit comme facteur limitant de la performance en hypoxie sévère.

Post-exercise parasympathetic reactivation and sensibility to hypoxia

Introduction Exposure to hypoxia leads to several reactions of the organism, which try to compensate the reduced oxygen level in the blood. Acute response is characterized by an increase in pulmonary ventilation (Hypoxia Ventilatory Response, HVR) and in cardiac output (cardiac response to hypoxia). Heart rate (HR) at rest and during exercise is higher at high altitude than at sea level, whereas HRmax is lower. These cardiac adaptations are partially explained by an increased sympathetic stimulation associated with a reduced parasympathetic tone (12). The precise mechanisms of HRmax decline in acute hypoxia are however still to be identified, although several hypothesis have been suggested, such as a direct effect of hypoxia on the electrophysiological properties, an influence of skeletal maximal VO2 or a modulation of the autonomic nervous system (8). Some authors have reported that endurance trained athletes present an increased sensitivity to hypoxia shown by a large reduction in VO2max and an important decrease in arterial saturation. (9,11, 13) A hypoxia test can assess the sensibility of chemoreceptors to the reduction of oxygen by calculating hypoxic ventilatory and cardiac responses, knowing that low sensibility is correlated with poor acclimatization. Two parameters results from the differences in ventilation (and heart rate) divided by the difference in the arterial oxygen saturation between normoxia and hypoxia (18). Objective The hypothesis tested by this study is that parasympathetic reactivation after moderate effort in hypoxic condition can be used as a marker of individual sensibility to hypoxia. Parasympathetic reactivation is a marker of vagal tone that predict endurance capacity and aerobic fitness (2,7). Methods Subjects This study uses data obtained from two groups of athletes participating into two larger studies about adaptation to hypoxia. One group is composed of elite athletes (Swiss ski mountaineering team), the other one of mid-level athletes (ski mountaineering amateurs). The particularity of this target population is that they often train at high altitude, and therefore could show a better response to hypoxia than athleltes of other disciplines. Protocol The athletes performed a submaximal exercise (6min run at 9 km/h, flat) followed by 10 min of seated rest either in an hypoxic chamber (simulated altitude of 3000m) or in normoxic conditions. During the resting phase parasympathetic reactivation was assessed by beat-to-beat HR measurements.A test of tolerance to altitude was also performed. Analysis Parasympathetic reactivation, assessed by the calculation of the root mean square of successive differences in the R-R intervals (RMSSD)(4), is compared to individual responses at altitude, in order to appreciate the correlation between the two phenomena.

Two days of hypoxic exposure increased ventilation without affecting performance.

The aim of this study was to test the short-term effects of using hypoxic rooms before a simulated running event. Thirteen subjects (29 +/- 4 years) lived in a hypoxic dormitory (1,800 m) for either 2 nights (n = 6) or 2 days + nights (n = 7) before performing a 1,500-m treadmill test. Performance, expired gases, and muscle electrical activity were recorded and compared with a control session performed 1 week before or after the altitude session (random order). Arterial blood samples were collected before and after altitude exposure. Arterial pH and hemoglobin concentration increased (p < 0.05) and PCO2 decreased (p < 0.05) upon exiting the room. However, these parameters returned (p < 0.05) to basal levels within a few hours. During exercise, mean ventilation (VE) was higher (p < 0.05) after 2 nights or days + nights of moderate altitude exposure (113.0 +/- 27.2 L.min) than in the control run (108.6 +/- 27.8 L.min), without any modification in performance (360 +/- 45 vs. 360 +/- 42 seconds, respectively) or muscle electrical activity. This elevated VE during the run after the hypoxic exposure was probably because of the subsistence effects of the hypoxic ventilatory response. However, from a practical point of view, although the use of a normobaric simulating altitude chamber exposure induced some hematological adaptations, these disappeared within a few hours and failed to provide any benefit during the subsequent 1,500-m run.

Combining hypoxic methods for peak performance.

New methods and devices for pursuing performance enhancement through altitude training were developed in Scandinavia and the USA in the early 1990s. At present, several forms of hypoxic training and/or altitude exposure exist: traditional 'live high-train high' (LHTH), contemporary 'live high-train low' (LHTL), intermittent hypoxic exposure during rest (IHE) and intermittent hypoxic exposure during continuous session (IHT). Although substantial differences exist between these methods of hypoxic training and/or exposure, all have the same goal: to induce an improvement in athletic performance at sea level. They are also used for preparation for competition at altitude and/or for the acclimatization of mountaineers. The underlying mechanisms behind the effects of hypoxic training are widely debated. Although the popular view is that altitude training may lead to an increase in haematological capacity, this may not be the main, or the only, factor involved in the improvement of performance. Other central (such as ventilatory, haemodynamic or neural adaptation) or peripheral (such as muscle buffering capacity or economy) factors play an important role. LHTL was shown to be an efficient method. The optimal altitude for living high has been defined as being 2200-2500 m to provide an optimal erythropoietic effect and up to 3100 m for non-haematological parameters. The optimal duration at altitude appears to be 4 weeks for inducing accelerated erythropoiesis whereas &lt;3 weeks (i.e. 18 days) are long enough for beneficial changes in economy, muscle buffering capacity, the hypoxic ventilatory response or Na(+)/K(+)-ATPase activity. One critical point is the daily dose of altitude. A natural altitude of 2500 m for 20-22 h/day (in fact, travelling down to the valley only for training) appears sufficient to increase erythropoiesis and improve sea-level performance. 'Longer is better' as regards haematological changes since additional benefits have been shown as hypoxic exposure increases beyond 16 h/day. The minimum daily dose for stimulating erythropoiesis seems to be 12 h/day. For non-haematological changes, the implementation of a much shorter duration of exposure seems possible. Athletes could take advantage of IHT, which seems more beneficial than IHE in performance enhancement. The intensity of hypoxic exercise might play a role on adaptations at the molecular level in skeletal muscle tissue. There is clear evidence that intense exercise at high altitude stimulates to a greater extent muscle adaptations for both aerobic and anaerobic exercises and limits the decrease in power. So although IHT induces no increase in VO(2max) due to the low 'altitude dose', improvement in athletic performance is likely to happen with high-intensity exercise (i.e. above the ventilatory threshold) due to an increase in mitochondrial efficiency and pH/lactate regulation. We propose a new combination of hypoxic method (which we suggest naming Living High-Training Low and High, interspersed; LHTLHi) combining LHTL (five nights at 3000 m and two nights at sea level) with training at sea level except for a few (2.3 per week) IHT sessions of supra-threshold training. This review also provides a rationale on how to combine the different hypoxic methods and suggests advances in both their implementation and their periodization during the yearly training programme of athletes competing in endurance, glycolytic or intermittent sports.

The Effect of Adding CO2 to Hypoxic Inspired Gas on Cerebral Blood Flow Velocity and Breathing during Incremental Exercise

Hypoxia increases the ventilatory response to exercise, which leads to hyperventilation-induced hypocapnia and subsequent reduction in cerebral blood flow (CBF). We studied the effects of adding CO2 to a hypoxic inspired gas on CBF during heavy exercise in an altitude naïve population. We hypothesized that augmented inspired CO2 and hypoxia would exert synergistic effects on increasing CBF during exercise, which would improve exercise capacity compared to hypocapnic hypoxia. We also examined the responsiveness of CO2 and O2 chemoreception on the regulation ventilation (E) during incremental exercise. We measured middle cerebral artery velocity (MCAv; index of CBF), E, end-tidal PCO2, respiratory compensation threshold (RC) and ventilatory response to exercise (E slope) in ten healthy men during incremental cycling to exhaustion in normoxia and hypoxia (FIO2 = 0.10) with and without augmenting the fraction of inspired CO2 (FICO2). During exercise in normoxia, augmenting FICO2 elevated MCAv throughout exercise and lowered both RC onset andE slope below RC (P<0.05). In hypoxia, MCAv and E slope below RC during exercise were elevated, while the onset of RC occurred at lower exercise intensity (P<0.05). Augmenting FICO2 in hypoxia increased E at RC (P<0.05) but no difference was observed in RC onset, MCAv, or E slope below RC (P>0.05). The E slope above RC was unchanged with either hypoxia or augmented FICO2 (P>0.05). We found augmenting FICO2 increased CBF during sub-maximal exercise in normoxia, but not in hypoxia, indicating that the 'normal' cerebrovascular response to hypercapnia is blunted during exercise in hypoxia, possibly due to an exhaustion of cerebral vasodilatory reserve. This finding may explain the lack of improvement of exercise capacity in hypoxia with augmented CO2. Our data further indicate that, during exercise below RC, chemoreception is responsive, while above RC the ventilatory response to CO2 is blunted.

In search for better pharmacological prophylaxis for acute mountain sickness: looking in other directions.

Despite decades of research, the exact pathogenic mechanisms underlying acute mountain sickness (AMS) are still poorly understood. This fact frustrates the search for novel pharmacological prophylaxis for AMS. The prevailing view is that AMS results from an insufficient physiological response to hypoxia and that prophylaxis should aim at stimulating the response. Starting off from the opposite hypothesis that AMS may be caused by an initial excessive response to hypoxia, we suggest that directly or indirectly blunting-specific parts of the response might provide promising research alternatives. This reasoning is based on the observations that (i) humans, once acclimatized, can climb Mt Everest experiencing arterial partial oxygen pressures (PaO2 ) as low as 25 mmHg without AMS symptoms; (ii) paradoxically, AMS usually develops at much higher PaO2 levels; and (iii) several biomarkers, suggesting initial activation of specific pathways at such PaO2 , are correlated with AMS. Apart from looking for substances that stimulate certain hypoxia triggered effects, such as the ventilatory response to hypoxia, we suggest to also investigate pharmacological means aiming at blunting certain other specific hypoxia-activated pathways, or stimulating their agonists, in the quest for better pharmacological prophylaxis for AMS.

Effects of continuous vs interval exercise training on oxygen uptake efficiency slope in patients with coronary artery disease

The oxygen uptake efficiency slope (OUES) is a submaximal index incorporating cardiovascular, peripheral, and pulmonary factors that determine the ventilatory response to exercise. The purpose of this study was to evaluate the effects of continuous exercise training and interval exercise training on the OUES in patients with coronary artery disease. Thirty-five patients (59.3±1.8 years old; 28 men, 7 women) with coronary artery disease were randomly divided into two groups: continuous exercise training (n=18) and interval exercise training (n=17). All patients performed graded exercise tests with respiratory gas analysis before and 3 months after the exercise-training program to determine ventilatory anaerobic threshold (VAT), respiratory compensation point, and peak oxygen consumption (peak VO2). The OUES was assessed based on data from the second minute of exercise until exhaustion by calculating the slope of the linear relation between oxygen uptake and the logarithm of total ventilation. After the interventions, both groups showed increased aerobic fitness (P<0.05). In addition, both the continuous exercise and interval exercise training groups demonstrated an increase in OUES (P<0.05). Significant associations were observed in both groups: 1) continuous exercise training (OUES and peak VO2 r=0.57; OUES and VO2 VAT r=0.57); 2) interval exercise training (OUES and peak VO2 r=0.80; OUES and VO2 VAT r=0.67). Continuous and interval exercise training resulted in a similar increase in OUES among patients with coronary artery disease. These findings suggest that improvements in OUES among CAD patients after aerobic exercise training may be dependent on peripheral and central mechanisms.

Cafeina vs aminofilina para la apnea del prematuro: estudio randomizado

La apnea del prematuro es una patología frecuente que se presenta en el 85% de los recién nacidos menores de 34 semanas de edad gestacional y en el 95-100% de los menores de 28 semanas. Con respecto al peso al nacer, se manifiesta en el 92% de los de peso menor a 1250 gramos y en el 50% de los de peso menor a 1500 gramos. Desde 2003, se aprobó en Colombia el uso de citrato de cafeína para la prevención y el tratamiento de la apnea del prematuro, basados en la evidencia. Metodología: Se realizó un estudio de interención simple comparando el citrato de cafeína con la aminofilina para la prevención y manejo de la apnea en pretérminos menores de 35 semanas de edad. Resultados: Se incluyeron 118 recién nacidos pretérminos de los cuales 18,6% fueron menores de 28 semanas, 79,7% de 34 semanas y dos 1,7% mayores o iguales a 34,1 semanas. 56 neonatos recibieron citrato de cafeína. De éstos, 33,9% de forma profiláctica y 66,1%, terapéutica; 28 (23,7%) recibieron aminofilina y 34 (28,8%) no recibieron ninguno de los dos medicamentos. El citrato de cafeína mostró menos efectos secundarios comparado con aminofilina (p <0,01). Discusión: El citrato de cafeína, administrado en forma profiláctica o terapéutica, mostró resultados superiores, estadísticamente significativos, en comparación con aminofilina y con los controles sin tratamiento, para la prevención y el tratamiento de la apnea del prematuro, presentando, además, menores efectos secundarios.

Nucleus isthmi and control of breathing in amphibians

Despite recent advances, the mechanisms of neurorespiratory control in amphibians are far from understood. One of the brainstem structures believed to play a key role in the ventilatory control of anuran amphibians is the nucleus isthmi (NI). This nucleus is a mesencephalic structure located between the roof of the midbrain and the cerebellum, which differentiates during metamorphosis; the period when pulmonary ventilation develops in bullfrogs. It has been recently suggested that the NI acts to inhibit hypoxic and hypercarbic drives in breathing by restricting increases in tidal volume. This data is similar to the influence of two pontine structures of mammals, the locus coeruleus and the nucleus raphe magnus. The putative mediators for this response are glutamate and nitric oxide. Microinjection of kynurenic acid (an ionotropic receptor antagonist of excitatory amino acids) and L-NAME (a non-selective NO synthase inhibitor) elicited increases in the ventilatory response to hypoxia and hypercarbia. This article reviews the available data on the role of the NI in the control of ventilation in amphibians. (C) 2004 Elsevier B.V. All rights reserved.

Locus coeruleus is a central chemoreceptive site in toads

The locus coeruleus (LC) has been suggested as a CO2 chemoreceptor site in mammals. This nucleus is a mesencephalic structure of the amphibian brain and is probably homologous to the LC in mammals. There are no data available for the role of LC in the central chemoreception of amphibians. Thus the present study was designed to investigate whether LC of toads (Bufo schneideri) is a CO2/H+ chemoreceptor site. Fos immunoreactivity was used to verify whether the nucleus is activated by hypercarbia (5% CO2 in air). In addition, we assessed the role of noradrenergic LC neurons on respiratory and cardiovascular responses to hypercarbia by using 6-hydroxydopamine lesion. To further explore the role of LC in central chemosensitivity, we examined the effects of microinjection of solutions with different pH values (7.2, 7.4, 7.6, 7.8, and 8.0) into the nucleus. Our main findings were that 1) a marked increase in c-fos-positive cells in the LC was induced after 3 h of breathing a hypercarbic gas mixture; 2) chemical lesions in the LC attenuated the increase of the ventilatory response to hypercarbia but did not affect ventilation under resting conditions; and 3) microinjection with acid solutions (pH = 7.2, 7.4, and 7.6) into the LC elicited an increased ventilation, indicating that the LC of toads participates in the central chemoreception.

Ionotropic glutamatergic receptors in the rostral medullary raphe modulate hypoxia and hypercapnia-induced hyperpnea

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)